References: Medication and Treatment


Barkley, R.A. & Peters, H. (2012). The earliest reference to adhd in the medical
literature? melchior adam weikard’s description in 1775 of “attention deficit” (mangel der aufmerksamkeit, attentio volubilis). Journal of Attention Disorders, 16(8), 623-630.

Chronis, A.M., Jones, H.A. & Raggi, V.L. (2006). Evidence based psychosocialtreatments for children and adolescents with attention-deficit/hyperactivity disorder. Clinical Psychology Review 26(4), 486-502. Retrieved from:

Conners, C.K. & Eisenberg, L. (1963). The effects of methylphenidate on symptomatology and learning in disturbed children. American Journal of Psychiatry, 120(5), 458-464.

DuPaul, G.J., & Eckert, T.L. (1997). The effects of school-based interventions for attention deficit hyperactivity disorder: A meta-analysis. School Psychology Review, 26, 5-27.

Freed, H. & Peifer, C.A. (1956). Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chlorpromazine. American Journal of Psychiatry, 113, 22-26

Hanwella, R., Senanayake, M., & de Silva, V. (2011). Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry, 11,176. doi: 10.1186/1471-244X-11-176.

LeFever, G.B., Arcona, A.P., Antonuccio, D.O. (2003). ADHD among American schoolchildren: Evidence of overdiagnosis and overuse of medication. The Scientific Review of Mental Health Practice, 2(1).

Mays, R. (2006). Suffer the restless children: The evolution of adhd and pediatric stimulant use, 1900-1980. Retrieved from:

National Institutes of Health. (1998). Diagnosis and treatment of attention-deficit/hyperactivity disorder. NIH Consensus Statement Online 1998 Nov 16-18; 16(2): 1-37. Retrieved from:

O’Leary, K.D., Becker, W.C., Evans, M.B., & Saudargas, R.A. (1969). A token reinforcement program in public school: A replication and systematic analysis. Journal of Applied Behavioral Analysis, 2(1), 3-13.

Pelham, W.E., Burrows-MacLean, L., Gnagy, E.M., Fabiano, G.A., Coles, E.K., Tresco, K.E., Chacko, A., Wymbs, B.T., Wienke, A.L., Walker, K.S., & Hoffman, M.T. (2005). Transdermal methylphenidate, behavioral, and combined treatment for children with adhd. Experimental and Clinical Psychopharmacology, 13(2), 111-126. doi: 10.1037/1064-1297.13.2.111.

Pelham, W.E., Gnagy, E.M., Greiner, A.R., Hoza, B., Hinshaw, S.P., Swanson, J.M., Simpson, S., Shapiro, C., Bukstein, O., Baron-Myak, C., & McBurnett, K. (2000). Behavioral versus behavioral and pharmacological treatment in adhd children attending a summer treatment program. Journal of Abnormal Child Psychology, 28(6), 507-525.

Strohl, M.P. (2011). Bradley’s benzedrine studies on children with behavioral disorders.Yale Journal of Biology and Medicine, 84(1), 27-33.

Leave a Reply